Clinical Trials Browser

Phase 2/3 × Lung Neoplasms × Breast × Clear all

NCT01902823 2019-12-13

Effect of Cancer Nurse Navigators on Patient Outcomes

Phase 2/3 Terminated

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT00243685 2012-01-26

Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

Phase 2/3 Completed

BreastGynecologicSarcomaThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma